Aziyo Biologics Inc reports results for the quarter ended in June - Earnings Summary

Elutia

11/08/2022 22:40

* Aziyo Biologics Inc  AZYO.OQ  reported a quarterly
adjusted loss
of 69 cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 56 cents per share.
    * Revenue rose 3.9% to $12.64 million from a year ago;
analysts
expected $11.58 million. 
    * Aziyo Biologics Inc's reported EPS for the quarter was a
loss
of 69 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Aziyo Biologics Inc shares had fallen by 8.8% this
quarter and
gained 2.4% so far this year.
    * The company reported a quarterly loss of $9.39 million.
    * Wall Street's median 12-month price target for Aziyo
Biologics
Inc is $10.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 09:40 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.56          -0.69          Missed
 Mar. 31 2022      -0.62          -0.60          Beat
 Dec. 31 2021      -0.68          -0.82          Missed
 Sep. 30 2021      -0.62          -0.81          Missed